Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
Coming Soon: ‘Wegovy HD’
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
Could GLP-1 drugs help your mental health? New study finds a link – National
It’s not just weight loss and diabetes: GLP-1 drugs like Ozempic and Wegovy may also help patients suffering…
What to Know about the Experimental GLP-1 Drug CagriSema
3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Weight-loss wegovy jab may carry greater risk of sudden sight loss, study finds – The Irish Times
Patients taking Wegovy have nearly five times the risk of sudden sight loss compared with those on Ozempic,…
Has anyone died from taking GLP-1 weight-loss drugs? – Baltimore Sun
Has anyone died from taking GLP-1 weight-loss drugs? Baltimore SunPAHO calls for strengthened pharmacovigilance following reports of misuse of…
GLP-1 Patients Report New Side Effect—and It’s Worse Than ‘Ozempic Face’
Tatsiana Volkava/Getty Images A newly reported side effect of the popular GLP-1 weight loss drugs may be its…
Mounjaro and Wegovy ‘worse off than before’ warning
A Cambridge University study found people who stop taking weight loss jabs such as Mounjaro and Wegovy regain…
Weight loss jab users warned they could be ‘worse off than before’
Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
Lost insurance coverage for GLP-1 weight-loss drugs? Tell us.
With health care spending on wildly popular GLP-1 drugs for weight loss soaring, local insurers got stricter this…